Trial intelligence / Profile preview

Brinzolamide/Timolol Fixed Combination vs COSOPT in Open-Angle Glaucoma or Ocular Hypertension

2005-004766-16Phase 3Completed

Sponsor
Alcon Inc.
Start
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of Azorga in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Primary: Non-inferiority in IOP-lowering efficacy. Started Dec 2005; status: completed.

02

Drugs

Azorga
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on 2005-004766-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004766-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call